Enacted — Signed by the President — Jul 9, 2012
Last Action: Signed by President.
Explanation: This bill was enacted after being signed by the President on July 9, 2012.
Kickstarter calls GovTrack Insider a “Project We Love”
We’re trying to hire a full-time researcher, but we need your help.
May 15, 2012
112th Congress, 2011–2013
Enacted — Signed by the President on Jul 9, 2012
This bill was enacted after being signed by the President on July 9, 2012.
Senator from Iowa
Read Text »
Last Updated: Jun 27, 2012
Length: 140 pages
A bill to amend the Federal Food, Drug, and Cosmetic Act to revise and extend the user-fee programs for prescription drugs and medical devices, to establish user-fee programs for generic drugs and biosimilars, and for other purposes.
Legislative action may be ocurring on one of these bills in lieu of or in parallel to action on this bill.
Reported by Committee
Last Action: May 7, 2012
Last Action: May 30, 2012
The “S.” in “S. 3187” means this is a Senate bill in the United States Congress. A bill must be passed by both the House and Senate in identical form and then be signed by the President to become law.
Search for similar bills.
Click a format for a citation suggestion:
Civic Impulse. (2015). S. 3187 — 112th Congress: Food and Drug Administration Safety and Innovation Act. Retrieved from https://www.govtrack.us/congress/bills/112/s3187
“S. 3187 — 112th Congress: Food and Drug Administration Safety and Innovation Act.” www.GovTrack.us. 2012. August 28, 2015 <https://www.govtrack.us/congress/bills/112/s3187>
|title=S. 3187 (112th)
|accessdate=August 28, 2015
|author=112th Congress (2012)
|date=May 15, 2012
|quote=Food and Drug Administration Safety and Innovation Act